nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Immunodeficiency—Methotrexate—bone cancer	0.0562	0.0562	CcSEcCtD
Entecavir—Hepatic cirrhosis—Methotrexate—bone cancer	0.0509	0.0509	CcSEcCtD
Entecavir—Lactic acidosis—Epirubicin—bone cancer	0.0374	0.0374	CcSEcCtD
Entecavir—Lactic acidosis—Doxorubicin—bone cancer	0.0346	0.0346	CcSEcCtD
Entecavir—Serum creatinine increased—Cisplatin—bone cancer	0.0289	0.0289	CcSEcCtD
Entecavir—Laboratory test abnormal—Epirubicin—bone cancer	0.0218	0.0218	CcSEcCtD
Entecavir—Infection—Carboplatin—bone cancer	0.0215	0.0215	CcSEcCtD
Entecavir—Laboratory test abnormal—Doxorubicin—bone cancer	0.0202	0.0202	CcSEcCtD
Entecavir—Ascites—Epirubicin—bone cancer	0.0201	0.0201	CcSEcCtD
Entecavir—Ascites—Doxorubicin—bone cancer	0.0186	0.0186	CcSEcCtD
Entecavir—Body temperature increased—Carboplatin—bone cancer	0.0171	0.0171	CcSEcCtD
Entecavir—Transaminases increased—Epirubicin—bone cancer	0.015	0.015	CcSEcCtD
Entecavir—Serum creatinine increased—Epirubicin—bone cancer	0.0148	0.0148	CcSEcCtD
Entecavir—Transaminases increased—Doxorubicin—bone cancer	0.0139	0.0139	CcSEcCtD
Entecavir—Serum creatinine increased—Doxorubicin—bone cancer	0.0137	0.0137	CcSEcCtD
Entecavir—Anaphylactoid reaction—Cisplatin—bone cancer	0.0133	0.0133	CcSEcCtD
Entecavir—Hepatomegaly—Epirubicin—bone cancer	0.0129	0.0129	CcSEcCtD
Entecavir—Blood creatinine increased—Cisplatin—bone cancer	0.0121	0.0121	CcSEcCtD
Entecavir—Hepatomegaly—Doxorubicin—bone cancer	0.0119	0.0119	CcSEcCtD
Entecavir—Glycosuria—Epirubicin—bone cancer	0.0113	0.0113	CcSEcCtD
Entecavir—Pancreatitis—Cisplatin—bone cancer	0.0109	0.0109	CcSEcCtD
Entecavir—Glycosuria—Doxorubicin—bone cancer	0.0104	0.0104	CcSEcCtD
Entecavir—Renal failure—Cisplatin—bone cancer	0.00977	0.00977	CcSEcCtD
Entecavir—Hepatobiliary disease—Cisplatin—bone cancer	0.0094	0.0094	CcSEcCtD
Entecavir—Immune system disorder—Cisplatin—bone cancer	0.00806	0.00806	CcSEcCtD
Entecavir—Alopecia—Cisplatin—bone cancer	0.00789	0.00789	CcSEcCtD
Entecavir—Hepatic failure—Methotrexate—bone cancer	0.00788	0.00788	CcSEcCtD
Entecavir—Malnutrition—Cisplatin—bone cancer	0.00777	0.00777	CcSEcCtD
Entecavir—Hepatic failure—Epirubicin—bone cancer	0.00737	0.00737	CcSEcCtD
Entecavir—Anaphylactoid reaction—Methotrexate—bone cancer	0.00731	0.00731	CcSEcCtD
Entecavir—Leukopenia—Cisplatin—bone cancer	0.00695	0.00695	CcSEcCtD
Entecavir—Anaphylactoid reaction—Epirubicin—bone cancer	0.00684	0.00684	CcSEcCtD
Entecavir—Hepatic failure—Doxorubicin—bone cancer	0.00682	0.00682	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00657	0.00657	CcSEcCtD
Entecavir—Anaphylactic shock—Cisplatin—bone cancer	0.00634	0.00634	CcSEcCtD
Entecavir—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00633	0.00633	CcSEcCtD
Entecavir—Infection—Cisplatin—bone cancer	0.0063	0.0063	CcSEcCtD
Entecavir—Nervous system disorder—Cisplatin—bone cancer	0.00622	0.00622	CcSEcCtD
Entecavir—Blood creatinine increased—Epirubicin—bone cancer	0.00621	0.00621	CcSEcCtD
Entecavir—Skin disorder—Cisplatin—bone cancer	0.00616	0.00616	CcSEcCtD
Entecavir—Abdominal pain upper—Epirubicin—bone cancer	0.00605	0.00605	CcSEcCtD
Entecavir—Pancreatitis—Methotrexate—bone cancer	0.006	0.006	CcSEcCtD
Entecavir—Blood creatinine increased—Doxorubicin—bone cancer	0.00574	0.00574	CcSEcCtD
Entecavir—Neutropenia—Methotrexate—bone cancer	0.00572	0.00572	CcSEcCtD
Entecavir—Upper respiratory tract infection—Methotrexate—bone cancer	0.00569	0.00569	CcSEcCtD
Entecavir—Pancreatitis—Epirubicin—bone cancer	0.00561	0.00561	CcSEcCtD
Entecavir—Abdominal pain upper—Doxorubicin—bone cancer	0.0056	0.0056	CcSEcCtD
Entecavir—Gastrointestinal disorder—Cisplatin—bone cancer	0.00547	0.00547	CcSEcCtD
Entecavir—Renal failure—Methotrexate—bone cancer	0.00536	0.00536	CcSEcCtD
Entecavir—Neutropenia—Epirubicin—bone cancer	0.00535	0.00535	CcSEcCtD
Entecavir—Upper respiratory tract infection—Epirubicin—bone cancer	0.00532	0.00532	CcSEcCtD
Entecavir—Haematuria—Methotrexate—bone cancer	0.0052	0.0052	CcSEcCtD
Entecavir—Pancreatitis—Doxorubicin—bone cancer	0.00519	0.00519	CcSEcCtD
Entecavir—Hyperglycaemia—Epirubicin—bone cancer	0.00517	0.00517	CcSEcCtD
Entecavir—Hepatobiliary disease—Methotrexate—bone cancer	0.00516	0.00516	CcSEcCtD
Entecavir—Renal failure—Epirubicin—bone cancer	0.00502	0.00502	CcSEcCtD
Entecavir—Body temperature increased—Cisplatin—bone cancer	0.00501	0.00501	CcSEcCtD
Entecavir—Neutropenia—Doxorubicin—bone cancer	0.00495	0.00495	CcSEcCtD
Entecavir—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00492	0.00492	CcSEcCtD
Entecavir—Hepatitis—Methotrexate—bone cancer	0.0049	0.0049	CcSEcCtD
Entecavir—Haematuria—Epirubicin—bone cancer	0.00487	0.00487	CcSEcCtD
Entecavir—Hepatobiliary disease—Epirubicin—bone cancer	0.00483	0.00483	CcSEcCtD
Entecavir—Hyperglycaemia—Doxorubicin—bone cancer	0.00478	0.00478	CcSEcCtD
Entecavir—Renal failure—Doxorubicin—bone cancer	0.00464	0.00464	CcSEcCtD
Entecavir—Hepatitis—Epirubicin—bone cancer	0.00458	0.00458	CcSEcCtD
Entecavir—Asthenia—Cisplatin—bone cancer	0.00455	0.00455	CcSEcCtD
Entecavir—Oedema peripheral—Epirubicin—bone cancer	0.00451	0.00451	CcSEcCtD
Entecavir—Haematuria—Doxorubicin—bone cancer	0.0045	0.0045	CcSEcCtD
Entecavir—Hepatobiliary disease—Doxorubicin—bone cancer	0.00447	0.00447	CcSEcCtD
Entecavir—Immune system disorder—Methotrexate—bone cancer	0.00442	0.00442	CcSEcCtD
Entecavir—Diarrhoea—Cisplatin—bone cancer	0.00434	0.00434	CcSEcCtD
Entecavir—Alopecia—Methotrexate—bone cancer	0.00433	0.00433	CcSEcCtD
Entecavir—Mental disorder—Methotrexate—bone cancer	0.00429	0.00429	CcSEcCtD
Entecavir—Malnutrition—Methotrexate—bone cancer	0.00426	0.00426	CcSEcCtD
Entecavir—Hepatitis—Doxorubicin—bone cancer	0.00424	0.00424	CcSEcCtD
Entecavir—Oedema peripheral—Doxorubicin—bone cancer	0.00418	0.00418	CcSEcCtD
Entecavir—Immune system disorder—Epirubicin—bone cancer	0.00414	0.00414	CcSEcCtD
Entecavir—Alopecia—Epirubicin—bone cancer	0.00405	0.00405	CcSEcCtD
Entecavir—Vomiting—Cisplatin—bone cancer	0.00403	0.00403	CcSEcCtD
Entecavir—Mental disorder—Epirubicin—bone cancer	0.00402	0.00402	CcSEcCtD
Entecavir—Rash—Cisplatin—bone cancer	0.004	0.004	CcSEcCtD
Entecavir—Dermatitis—Cisplatin—bone cancer	0.00399	0.00399	CcSEcCtD
Entecavir—Malnutrition—Epirubicin—bone cancer	0.00399	0.00399	CcSEcCtD
Entecavir—Immune system disorder—Doxorubicin—bone cancer	0.00383	0.00383	CcSEcCtD
Entecavir—Leukopenia—Methotrexate—bone cancer	0.00382	0.00382	CcSEcCtD
Entecavir—Nausea—Cisplatin—bone cancer	0.00377	0.00377	CcSEcCtD
Entecavir—Alopecia—Doxorubicin—bone cancer	0.00375	0.00375	CcSEcCtD
Entecavir—Mental disorder—Doxorubicin—bone cancer	0.00372	0.00372	CcSEcCtD
Entecavir—Malnutrition—Doxorubicin—bone cancer	0.00369	0.00369	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.0036	0.0036	CcSEcCtD
Entecavir—Leukopenia—Epirubicin—bone cancer	0.00357	0.00357	CcSEcCtD
Entecavir—Anaphylactic shock—Methotrexate—bone cancer	0.00348	0.00348	CcSEcCtD
Entecavir—Infection—Methotrexate—bone cancer	0.00346	0.00346	CcSEcCtD
Entecavir—Nervous system disorder—Methotrexate—bone cancer	0.00341	0.00341	CcSEcCtD
Entecavir—Skin disorder—Methotrexate—bone cancer	0.00338	0.00338	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00337	0.00337	CcSEcCtD
Entecavir—Leukopenia—Doxorubicin—bone cancer	0.0033	0.0033	CcSEcCtD
Entecavir—Anaphylactic shock—Epirubicin—bone cancer	0.00326	0.00326	CcSEcCtD
Entecavir—Infection—Epirubicin—bone cancer	0.00323	0.00323	CcSEcCtD
Entecavir—Nervous system disorder—Epirubicin—bone cancer	0.00319	0.00319	CcSEcCtD
Entecavir—Skin disorder—Epirubicin—bone cancer	0.00316	0.00316	CcSEcCtD
Entecavir—Insomnia—Methotrexate—bone cancer	0.00315	0.00315	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00312	0.00312	CcSEcCtD
Entecavir—Somnolence—Methotrexate—bone cancer	0.00309	0.00309	CcSEcCtD
Entecavir—Dyspepsia—Methotrexate—bone cancer	0.00306	0.00306	CcSEcCtD
Entecavir—Anaphylactic shock—Doxorubicin—bone cancer	0.00301	0.00301	CcSEcCtD
Entecavir—Gastrointestinal disorder—Methotrexate—bone cancer	0.003	0.003	CcSEcCtD
Entecavir—Fatigue—Methotrexate—bone cancer	0.003	0.003	CcSEcCtD
Entecavir—Infection—Doxorubicin—bone cancer	0.00299	0.00299	CcSEcCtD
Entecavir—Nervous system disorder—Doxorubicin—bone cancer	0.00295	0.00295	CcSEcCtD
Entecavir—Insomnia—Epirubicin—bone cancer	0.00294	0.00294	CcSEcCtD
Entecavir—Skin disorder—Doxorubicin—bone cancer	0.00293	0.00293	CcSEcCtD
Entecavir—Somnolence—Epirubicin—bone cancer	0.00289	0.00289	CcSEcCtD
Entecavir—Dyspepsia—Epirubicin—bone cancer	0.00287	0.00287	CcSEcCtD
Entecavir—Gastrointestinal pain—Methotrexate—bone cancer	0.00285	0.00285	CcSEcCtD
Entecavir—Gastrointestinal disorder—Epirubicin—bone cancer	0.00281	0.00281	CcSEcCtD
Entecavir—Fatigue—Epirubicin—bone cancer	0.00281	0.00281	CcSEcCtD
Entecavir—Abdominal pain—Methotrexate—bone cancer	0.00275	0.00275	CcSEcCtD
Entecavir—Body temperature increased—Methotrexate—bone cancer	0.00275	0.00275	CcSEcCtD
Entecavir—Insomnia—Doxorubicin—bone cancer	0.00272	0.00272	CcSEcCtD
Entecavir—Somnolence—Doxorubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Entecavir—Gastrointestinal pain—Epirubicin—bone cancer	0.00266	0.00266	CcSEcCtD
Entecavir—Dyspepsia—Doxorubicin—bone cancer	0.00265	0.00265	CcSEcCtD
Entecavir—Gastrointestinal disorder—Doxorubicin—bone cancer	0.0026	0.0026	CcSEcCtD
Entecavir—Fatigue—Doxorubicin—bone cancer	0.0026	0.0026	CcSEcCtD
Entecavir—Abdominal pain—Epirubicin—bone cancer	0.00257	0.00257	CcSEcCtD
Entecavir—Body temperature increased—Epirubicin—bone cancer	0.00257	0.00257	CcSEcCtD
Entecavir—Asthenia—Methotrexate—bone cancer	0.0025	0.0025	CcSEcCtD
Entecavir—Gastrointestinal pain—Doxorubicin—bone cancer	0.00246	0.00246	CcSEcCtD
Entecavir—Abdominal pain—Doxorubicin—bone cancer	0.00238	0.00238	CcSEcCtD
Entecavir—Body temperature increased—Doxorubicin—bone cancer	0.00238	0.00238	CcSEcCtD
Entecavir—Diarrhoea—Methotrexate—bone cancer	0.00238	0.00238	CcSEcCtD
Entecavir—Asthenia—Epirubicin—bone cancer	0.00234	0.00234	CcSEcCtD
Entecavir—Dizziness—Methotrexate—bone cancer	0.0023	0.0023	CcSEcCtD
Entecavir—Diarrhoea—Epirubicin—bone cancer	0.00223	0.00223	CcSEcCtD
Entecavir—Vomiting—Methotrexate—bone cancer	0.00221	0.00221	CcSEcCtD
Entecavir—Rash—Methotrexate—bone cancer	0.00219	0.00219	CcSEcCtD
Entecavir—Dermatitis—Methotrexate—bone cancer	0.00219	0.00219	CcSEcCtD
Entecavir—Headache—Methotrexate—bone cancer	0.00218	0.00218	CcSEcCtD
Entecavir—Asthenia—Doxorubicin—bone cancer	0.00216	0.00216	CcSEcCtD
Entecavir—Dizziness—Epirubicin—bone cancer	0.00215	0.00215	CcSEcCtD
Entecavir—Vomiting—Epirubicin—bone cancer	0.00207	0.00207	CcSEcCtD
Entecavir—Nausea—Methotrexate—bone cancer	0.00207	0.00207	CcSEcCtD
Entecavir—Diarrhoea—Doxorubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Entecavir—Rash—Epirubicin—bone cancer	0.00205	0.00205	CcSEcCtD
Entecavir—Dermatitis—Epirubicin—bone cancer	0.00205	0.00205	CcSEcCtD
Entecavir—Headache—Epirubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Entecavir—Dizziness—Doxorubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Entecavir—Nausea—Epirubicin—bone cancer	0.00193	0.00193	CcSEcCtD
Entecavir—Vomiting—Doxorubicin—bone cancer	0.00192	0.00192	CcSEcCtD
Entecavir—Rash—Doxorubicin—bone cancer	0.0019	0.0019	CcSEcCtD
Entecavir—Dermatitis—Doxorubicin—bone cancer	0.0019	0.0019	CcSEcCtD
Entecavir—Headache—Doxorubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Entecavir—Nausea—Doxorubicin—bone cancer	0.00179	0.00179	CcSEcCtD
